You are here: All Products > Innovent Out-licenses US-Canada Rights for Avastin Biosimilar to Coherus In $45 Million Deal
Innovent Out-licenses US-Canada Rights for Avastin Biosimilar to Coherus In $45 Million Deal
You are here: All Products > Innovent Out-licenses US-Canada Rights for Avastin Biosimilar to Coherus In $45 Million Deal